Open Access

Opinion of Academicians Regarding the Use of the CRISPR-Cas System in Türkiye

1 Uşak University, Eşme Vocational School, Laborant and Veterinary Health Program, Uşak
2 Kırıkkale University, Faculty of Veterinary Medicine, Department of Livestock Economics and Management, Kırıkkale

Abstract

The field of gene control is huge and still much unexplored, and one way to modify and alter genes is called CRISPR. The purpose of this study is to discuss the application of the CRISPR-Cas system in Turkey and find out what genetics professors think about it, as it has been a hot topic lately. The study's findings came from a survey that was given to 26 academicians who agreed to engage in the research and are recognized authorities in their professions. According to 74.1 % of participants, CRISPR-Cas 9 was not well known in the Turkish genetics community and was only known by those in the field. The participants stated that the CRISPR method can be used to treat cancer and many genetic diseases 100 % of the time, to breed animals for high-yield breeds in animal husbandry 100 % of the time, to provide resistance and protection against many infectious diseases 84.6 % of the time, and to improve animal welfare 88.8 % of the time. Although 76.9 % of experts said that there is room for ethical debate over the use of CRISPR, 92.3 % of experts predicted that gene-edited animal farms will be built in the near future. A sizable majority of participants 92.3 % said that Turkey must develop and apply the CRISPR method to stay ahead of developed nations in genetic science, as well as for application in animal breeding and the treatment of genetic illnesses. Therefore, even if CRISPR technology has benefits and drawbacks, it's critical to create legislative guidelines that consider the environment, public health, food safety, global trade, and the moral implications of the CRISPR technique.

Keywords

How to Cite

BİLİCİ, E., & DEMİR AYVAZOĞLU, P. . (2024). Opinion of Academicians Regarding the Use of the CRISPR-Cas System in Türkiye. ISPEC Journal of Agricultural Sciences, 8(4), 1086–1098. https://doi.org/10.5281/zenodo.13827271

References

📄 Akram, F., Haq, I.U.L., Ahmed, Z., Khan, H., Ali, M.S., 2020. CRISPR-Cas9, a promising therapeutic tool for cancer therapy: A review. Protein and peptide letters. 27(10): 931–944.
📄 Akram, F., Sahreen, S., Aamir, F., Malik, U.L., Imtiaz, K., Naseem, M., Nasir, W., N. Waheed, H.F., 2023. An insight into modern targeted genome-editing technologies with a special focus on CRISPR/Cas9 and its applications, Molecular Biotechnology, 65(2): 227–242.
📄 Ayanoğlu, F.B., Elçin, A.E., Elçin, Y.M., 2020. CRISPR-Cas9 teknolojisi ile genom düzenlemede biyoetik sorunlar. Türk Biyoloji Dergisi, 44(2):110–120.
📄 Bolukbas, A., Gucukoglu, A., 2022. CRISPR/Cas9 teknolojisi ve gıda alanında kullanımı. Frontiers in Life Sciences and Related Technologies 3(1): 36-42.
📄 Brokowski, C., Adli, M., 2019. CRISPR ethics: Moral considerations for applications of a powerful tool. Journal of Molecular Biology, 431:88–101.